Health Care During Third World / Developing Countries

1675 Words7 Pages
Health care in third-world/developing countries is vastly different than that health care in first-world/developed countries. In 1994, AZT became the first approved treatment for HIV. Pertinent studies showed that prenatal administration of AZT to HIV positive pregnant and subsequent postnatal administration to their babies resulted in a reducing mother to infant transmission from 25% to 8%. This change in the course of such a devastating illness helped to alter the mindset that having HIV was a death sentence. AZT was shown to slow the spread HIV significantly. It is important to note that AZT cannot stop the spread of HIV completely, but it is a viable treatment method that attempts to control and slow the condition. The AIDS pandemic spread across the globe in an uneven fashion. It was clear that HIV/AIDS was primarily affecting third world countries the most severely. Though an expensive drug, the “076” cocktail proved to be the most effective treatment in even short-term dosages. “The 076 [long course] regimen was a complicated one, involving five daily oral doses of AZT over an average of twelve weeks of pregnancy intravenous administration of AZT during labor and delivery, and six weeks of postpartum AZT for the infant” (Scott 1999, 544). While the treatment had been shown to reduce the transmission of HIV during pregnancy and delivery greatly, most public health experts agreed (at the ime) that the “076” regimen was impractical for many reasons. Women in
Open Document